
Summary:
In this podcast, recorded at the 2024 Patients as Partners Europe conference, GSK and Ovacome present how they developed a unique, mutually beneficial partnership that allowed GSK to explore the entire patient experience when living with a disease in a real-world setting, and gain insights from patient organizations to drive actionable change within clinical research. The Ovacome-GSK partnership impacted the full product lifecycle, by focusing on the entire patient experience, not just the narrow amount of time they're eligible for a trial.
This presentation covers the impact of a pharma-patient organization partnership on:
- Patient Engagement Tools
- Addressing Health Inequality within the patient community
- Real-world evidence generation
Related Podcasts
View All
How Roche Maximizes the Impact of Patient Insights in Early Development for a Blueprint to De-Risk Molecule Development

Working with Patient Organizations to Use Patient Insights Meaningfully throughout Medicine & Disease Lifecycles

Simplicity in Technology Delivery for Clinical Trials
